Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4783983
Max Phase: Preclinical
Molecular Formula: C31H30N4O4
Molecular Weight: 522.61
Molecule Type: Unknown
Associated Items:
ID: ALA4783983
Max Phase: Preclinical
Molecular Formula: C31H30N4O4
Molecular Weight: 522.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(CNc2ccc(CN[C@H](CO)C(=O)O)c(OCc3cncc(C#N)c3)c2)cccc1-c1ccccc1
Standard InChI: InChI=1S/C31H30N4O4/c1-21-25(8-5-9-28(21)24-6-3-2-4-7-24)17-34-27-11-10-26(18-35-29(19-36)31(37)38)30(13-27)39-20-23-12-22(14-32)15-33-16-23/h2-13,15-16,29,34-36H,17-20H2,1H3,(H,37,38)/t29-/m1/s1
Standard InChI Key: VDWJLGFOIWCFQU-GDLZYMKVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 522.61 | Molecular Weight (Monoisotopic): 522.2267 | AlogP: 4.65 | #Rotatable Bonds: 12 |
Polar Surface Area: 127.50 | Molecular Species: ACID | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 0.32 | CX Basic pKa: 8.49 | CX LogP: 1.62 | CX LogD: 1.59 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.21 | Np Likeness Score: -0.82 |
1. Guo J,Luo L,Wang Z,Hu N,Wang W,Xie F,Liang E,Yan X,Xiao J,Li S. (2020) Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In Vivo., 63 (22): [PMID:33186040] [10.1021/acs.jmedchem.0c01329] |
Source(1):